AxoGen, Inc. Announces Commercial Release and First Clinical Implant of Avive™ Soft Tissue Membrane Nov 21, 2016
AxoGen, Inc. to Report Third Quarter Financial Results and Host Conference Call on Wednesday, November 2, 2016 Oct 19, 2016
AxoGen Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares Oct 13, 2016